Literature DB >> 6248821

Multiple sclerosis and viruses: an overview.

S D Cook, P C Dowling.   

Abstract

The evidence for a viral etiology of MS has been reviewed. The strongest evidence favoring a virus is based primarily on epidemiologic considerations. Less convincing evidence comes from pathologic studies, serology, lymphocyte reactivity to viral antigens, and reports of identification of virus in MS tissues. Animal models of viral demyelination exist, which may provide insight into possible etiologic agents and pathogenetic mechanisms. Considering all the data, it is clear that no agent can be convincingly linked to MS at the present time. If a single virus causes the majority of cases of MS, then a morbilliform virus--canine distemper--is a leading contender, because this agent is consistent with the epidemiologic and serologic findings and is highly neurovirulent for animals ranging from mice to primates. Since no virus fulfills the usual criteria for linking an infectious agent to a disease, other possibilities must be considered. If MS is caused by a single virus, it may be a common virus not presently considered as being associated with MS, or an agent as yet unidentified. It is also conceivable that multiple agents, acting alone or in concert, initiate the MS process, perhaps through a common immune-mediated pathway. In this regard, another human demyelinating disease--the Guillain-Barré syndrome--which may in some instances become a chronic remitting and relapsing disorder, is thought to be initiated by multiple infectious agents but to have an immunologic pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248821     DOI: 10.1212/wnl.30.7_part_2.80

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Ruth Ann Marrie; Christina Wolfson
Journal:  Can J Infect Dis       Date:  2002-03

2.  Focal liver lesions: a plan for management.

Authors:  J N Thompson; R Gibson; A Czerniak; L H Blumgart
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01

3.  Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

Authors:  G Birnbaum; L Kotilinek; M Schwartz; M Sternad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

4.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

5.  Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs.

Authors:  Qingyong Ji; Antoine Perchellet; Joan M Goverman
Journal:  Nat Immunol       Date:  2010-06-06       Impact factor: 25.606

Review 6.  Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Authors:  Lidia Fernández-Paredes; Rebeca Pérez de Diego; Clara de Andrés; Silvia Sánchez-Ramón
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

7.  Lymphocyte subpopulations in patients with multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

8.  Interferon in cerebrospinal fluid. A marker for viral persistence of canine distemper encephalomyelitis.

Authors:  S C Tsai; B A Summers; M J Appel
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

Review 9.  Interferons in multiple sclerosis. A review of the evidence.

Authors:  H S Panitch
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

Review 10.  Neuroimmunology in multiple sclerosis.

Authors:  C L Cazzullo; D Caputo; C Parravicini
Journal:  Ital J Neurol Sci       Date:  1983-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.